EMA HMPC Launches Calls for Submission of Scientific Data EMA HMPC Calls for Scientific Data EMA HMPC has launched calls for submission of scientific data for:... EMA HMPC Launches Calls for Submission of Scientific Data
MHRA Publishes Marketing Authorisations Granted in January 2022 MHRA’s list of marketing authorisations granted in January 2022 MHRA granted four OTC licences in January 2022. Details of these... MHRA Publishes Marketing Authorisations Granted in January 2022
MHRA Webinar – E-cigarette Submission Portal-2022 Updates, Requirements and Guidance MHRA Webinar – E-cigarette Submission Portal-2022 Updates, Requirements and Guidance Date/Time: Thursday 31 March 2022, 14:00-16:00The MHRA is hosting a... MHRA Webinar – E-cigarette Submission Portal-2022 Updates, Requirements and Guidance
MHRA Public Assessment Report – Reclassification of Buscopan IBS Relief, Hyoscine Butylbromide 10mg Tablets MHRA Public Assessment Report – Reclassification of Buscopan IBS Relief, Hyoscine Butylbromide 10mg Tablets MHRA has published the Public Assessment... MHRA Public Assessment Report – Reclassification of Buscopan IBS Relief, Hyoscine Butylbromide 10mg Tablets
EMA Webinars – Digital Application Dataset Integration Network Project – Slides and Recording EMA Webinars – Digital Application Dataset Integration Network Project Slides and Recording The European Medicines Agency (EMA) hosted a webinar... EMA Webinars – Digital Application Dataset Integration Network Project – Slides and Recording
CMDh Workplan to 2025 – Public Consultation CMDh Workplan to 2025 – Public Consultation The Co-ordination group for Mutual recognition and Decentralised procedures – human (CMDh) has published... CMDh Workplan to 2025 – Public Consultation
EMA – Coordination Centre for the Data Analysis and Real World Interrogation Network (DARWIN EU®) EMA – Coordination Centre for the Data Analysis and Real World Interrogation Network (DARWIN EU®) The European Medicines Agency (EMA)... EMA – Coordination Centre for the Data Analysis and Real World Interrogation Network (DARWIN EU®)
EMA HMPC Meeting Report – January 2022 EMA’s Committee on Herbal Medicinal Products (HMPC) has published the report from their January 2022 meeting EMA’s Committee on Herbal... EMA HMPC Meeting Report – January 2022
Recent updates to MHRA guidance – what has changed Recent updates to MHRA guidance – what has changed The MHRA has shared a summary overview of recent updates to... Recent updates to MHRA guidance – what has changed
Request for a Preliminary Ruling to the European Court of Justice – Distinction Between Food for Special Medical Purposes, Food Supplements and Medicinal Products Request for a Preliminary Ruling to the European Court of Justice (Case C-760/21) – Distinction between Food for Special Medical... Request for a Preliminary Ruling to the European Court of Justice – Distinction Between Food for Special Medical Purposes, Food Supplements and Medicinal Products
MHRA – UK Early Access to Medicines Scheme Consultation Outcome MHRA – UK Early Access to Medicines Scheme Consultation Outcome The MHRA ran a public consultation on a proposed statutory... MHRA – UK Early Access to Medicines Scheme Consultation Outcome
EMA Report – Learnings Initiative for Optimal Use of Big Data for Regulatory Purpose Workshop EMA Report – Learnings Initiative for Optimal Use of Big Data for Regulatory Purpose Workshop On 30 November 2021 EMA... EMA Report – Learnings Initiative for Optimal Use of Big Data for Regulatory Purpose Workshop
